产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 99% | 询价 | |||
| 5mg | 99% | 询价 | |||
| 10mg | 99% | 询价 | |||
| 25mg | 99% | 询价 | |||
| 50mg | 99% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 99% | 询价 | |||
| 5mg | 99% | 询价 | |||
| 10mg | 99% | 询价 | |||
| 25mg | 99% | 询价 | |||
| 50mg | 99% | 询价 |
CAS No. |
2056261-42-6 |
|---|---|
中文名称 |
BRD5648(研发代号/化合物编号,非IUPAC系统命名;需提供结构式、SMILES/InChI或完整英文IUPAC名以生成符合CCS的中文系统命名) |
英文名称 |
BRD5648 |
别名 |
BRD5648;(R)-BRD0705;compound,Glycogen synthase kinase 3,negative,Glycogen synthase kinase-3,BRD-5648,GSK-3,BRD5648,inhibit,BRD 5648,Inhibitor,(R)-enantiomer,control;5H-Pyrazolo[3,4-b]quinolin-5-one, 4-ethyl-1,2,4,6,7,8-hexahydro-7,7-dimethyl-4-phenyl-, (4R)-;BRD5648, 10 mM in DMSO;(4R)-4-Ethyl-7,7-dimethyl-4-phenyl-1,6,8,9-tetrahydropyrazolo[3,4-b]quinolin-5-one |
标准英文名 |
(R)-4-ethyl-7,7-dimethyl-4-phenyl-1,4,6,7,8,9-hexahydro-5H-pyrazolo[3,4-b]quinolin-5-one |
MDL No. |
MFCD32690086 |
分子式 |
C20H23N3O |
分子量 |
321.42 |
精确分子量 |
321.18 |
SMILES |
O=C1C2=C(CC(C)(C1)C)N=C3C([C@]2(C4=CC=CC=C4)CC)=CNN3 |
标准SMILES |
CC1(C)CC2N=C3NNC=C3[C@](CC)(C=2C(=O)C1)C1C=CC=CC=1 |
用途 |
BRD5648 ((R)-BRD0705) is a negative control for BRD0705, which is a potent, paralog-selective, and orally active GSK3α inhibitor (IC50 = 66 nM, Kd = 4.8 μM) with 8-fold selectivity over GSK3β (IC50 = 515 nM); BRD0705 is applicable for the treatment of acute myeloid leukemia. |
InChIKey |
NCKLQXXBRWCYMA-HXUWFJFHSA-N |
|
|
评论 |
|---|